This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in France report on the prognostic significance of anti-p53 and anti-KRAS circulating antibodies in patients with esophageal cancer. The team measured serum p53 and KRAS antibodies in 97 esophageal patients treated with chemoradiotherapy, and found that the 28 percent of them with anti-p53 antibodies had a shorter overall survival. None of the long-term survivors had these antibodies, the team adds.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.